An interventional study of MAGNET APPLICATION and REPROGRAMING in CARDIAC PACEMAKERS DEFIBRILLATOR ELECTROMAGNETIC, sponsored by Rambam Health Care Campus. Status unknown at 1 site in Israel. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-05-06.
Sponsored by Rambam Health Care Campus · Not applicable, Interventional, and Treatment
Data on the perioperative management of patients cardiac implantable electronic devices (CIEDs) is limited and published guidelines rely mainly on the experience of the cardiologists and anesthesiologists who manage these patients. Depending on the device type and patient's dependency, these guidelines recommend the intraoperative magnet use, reprogramming of devices or no action. Magnet placement on a CIED (very simple and applicable method) has become the standard approach in many centers, while CIED reprograming by trained personnel is required in most centers. Therefore, our objective is to compare in a prospective randomized clinical trial the safety of intraoperative magnet use vs. CIEDS reprogramming vs. no intervention (in the appropriate subjects)
Rambam Health Care Campus is the lead sponsor of 456 studies on the registry; 33 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
magnet application over cardiac device
Device: MAGNET APPLICATION
reprograming of cardiac device by trained technician/electrophysiologist
Device: REPROGRAMING
no action is performed if patient meets inclusion criteria
Device: NO ACTION
Any inappropriate sensing of EMI caused by electrocautery.
Time frame: DURING SURGERY/PROCEDURE
Any significant change in CIEDS parameters
Time frame: WITHIN 1 DAY OF SURGERY/PROCEDURE
This study is status unknown, as verified in May 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Rambam Health Care Campus